| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 MRC Retrovirus Research Laboratory, Department of Veterinary Pathology, University of Glasgow, Bearsden, Glasgow G61 1QH, U.K.
and2 Scripps Research Institute, 10666 North Torrey Pines Road, La Jolla, California 92037, U.S.A.
Nuclear protein binding sites in the long terminal repeat (LTR) of feline immunodeficiency virus (FIV) were identified by the method of DNase I footprinting. Using nuclear protein extracts from a feline T lymphoma cell line, several discrete footprints were generated upstream of the transcriptional initiation site (-50 to -150). The specificity of protein binding was examined by competition with oligonucleotides representing consensus DNA binding sites for known transcription factors. Binding to AP-1 (-124) and ATF (-58) motifs was observed, with cross-competition between these sites. A strong footprint signal was also detected over a tandemly repeated C/EBP motif (-94, -86) and an adjacent weaker footprint was found to be specific for an NF1 motif (-72/-63). The effect on FIV LTR promoter activity of progressively deleting these nuclear factor binding sites was examined by linking LTR deletion mutants to the chloramphenicol acetyltransferase (CAT) gene. Deletion of the AP-1 site caused a 10- to 25-fold loss of CAT activity whereas deletion past the ATF site reduced activity virtually to background levels. The effects of deleting the C/EBP and NF1 sites were less marked and varied according to cell type. Trans-activation of the LTR was assayed using constructs linked to a CAT reporter gene. The full-length FIV LTR was not significantly trans-activated. However, the expression of a deleted LTR construct lacking the AP-4/AP-1 site but retaining C/EBP and ATF sites was partially restored by co-infection with FIV or by co-transfection with an infectious molecular clone of FIV (FIV-PPR). These results show that host transcription factors responsive to cellular activation have a major role in regulating FIV expression, and suggest that virus-coded trans-activators acting through U3 may play a role in some cellular environments.
Received 24 September 1993;
accepted 19 November 1993.
This article has been cited by other articles:
|
|
 |
|
  S. de Rozieres, J. Thompson, M. Sundstrom, J. Gruber, D. S. Stump, A. P. de Parseval, S. VandeWoude, and J. H. Elder Replication Properties of Clade A/C Chimeric Feline Immunodeficiency Viruses and Evaluation of Infection Kinetics in the Domestic Cat J. Virol., August 15, 2008; 82(16): 7953 - 7963. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Q. Harper, P. D. Staber, C. R. Beck, S. K. Fineberg, C. Stein, D. Ochoa, and B. L. Davidson Optimization of Feline Immunodeficiency Virus Vectors for RNA Interference J. Virol., October 1, 2006; 80(19): 9371 - 9380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. O. Dowling and D. Bienzle Gene-expression changes induced by Feline immunodeficiency virus infection differ in epithelial cells and lymphocytes J. Gen. Virol., August 1, 2005; 86(8): 2239 - 2248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Joshi, H. Garg, M. B. Tompkins, and W. A. Tompkins Preferential Feline Immunodeficiency Virus (FIV) Infection of CD4+ CD25+ T-Regulatory Cells Correlates both with Surface Expression of CXCR4 and Activation of FIV Long Terminal Repeat Binding Cellular Transcriptional Factors J. Virol., April 15, 2005; 79(8): 4965 - 4976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Gemeniano, E. T. Sawai, C. M. Leutenegger, and E. E. Sparger Feline Immunodeficiency Virus Orf-A Is Required for Virus Particle Formation and Virus Infectivity J. Virol., August 15, 2003; 77(16): 8819 - 8830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Chatterji, A. de Parseval, and J. H. Elder Feline Immunodeficiency Virus OrfA Is Distinct from Other Lentivirus Transactivators J. Virol., August 28, 2002; 76(19): 9624 - 9634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Norway, P. C. Crawford, C. M. Johnson, and A. Mergia Thymic Lesions in Cats Infected with a Pathogenic Molecular Clone or an ORF-A/2-Deficient Molecular Clone of Feline Immunodeficiency Virus J. Virol., July 1, 2001; 75(13): 5833 - 5841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Bigornia, K. M. Lockridge, and E. E. Sparger Construction and In Vitro Characterization of Attenuated Feline Immunodeficiency Virus Long Terminal Repeat Mutant Viruses J. Virol., January 15, 2001; 75(2): 1054 - 1060. [Abstract] [Full Text]
|
|
|
|
|
|
A. de Parseval and J. H. Elder Demonstration that orf2 Encodes the Feline Immunodeficiency Virus Transactivating (Tat) Protein and Characterization of a Unique Gene Product with Partial Rev Activity J. Virol., January 1, 1999; 73(1): 608 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y Ikeda, Y Inoshima, Y Kawaguchi, K Maeda, M Kohmoto, C Kai, T Miyazawa, and T Mikami Protein-binding properties of the putative AP-1 and ATF sequences in the feline immunodeficiency virus long terminal repeat J. Gen. Virol., January 1, 1998; 79(1): 95 - 99. [Abstract]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
